FDA warns of possibly severe dental problems from oral, dissolvable buprenorphine News item 22 January 2022 Pages: 1 - 1
Precaution updates for blonanserin, fingolimod, posaconazole, suvorexant News item 22 January 2022 Pages: 3 - 3
XELJANZ/XELJANZ XR tofacitinib: risk of MACE, thrombosis, malignancy, infections News item 22 January 2022 Pages: 4 - 4
In utero statin exposure: risk of preterm birth and low birth weight Clinical study 22 January 2022 Pages: 5 - 5
Anaplastic lymphoma kinase inhibitor-related psychiatric disorders Clinical study 22 January 2022 Pages: 6 - 6
Fluzone High-dose Quadrivalent: no new safety concerns in US Clinical study 22 January 2022 Pages: 8 - 8
Pattern of vortioxine AEs generally consistent with those labelled, similar to SSRIs Clinical study 22 January 2022 Pages: 9 - 9
Sugammadex and neostigmine both comparably safe for reversal of neuromuscular blocks Clinical study 22 January 2022 Pages: 10 - 10
Transient increase in intussusception after Rotarix vaccination Clinical study 22 January 2022 Pages: 11 - 11
Use of INN imiglucerase without brand name impacts safety profile Unknown 22 January 2022 Pages: 12 - 12